Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Business Wire•29/10/2026•08:00 ET
0
Key Highlights
- ➤Twist launches MRD Express custom panels with turnaround starting within one day
- ➤MRD Express combines tumor-informed sensitivity with tumor-naïve testing speed
- ➤Custom panels support up to 10,000 probes for high-throughput MRD research
- ➤Twist says enhanced manufacturing and automation processes support personalized panel production at scale
Expert Statements
Emily M. Leproust, CEO and co-founder of Twist Bioscience
“To understand how cancer is responding at the molecular level, researchers need workflows that move as quickly as their questions demand”
Emily M. Leproust, CEO and co-founder of Twist Bioscience
“With personalized Twist MRD Express panels we are eliminating the tradeoff researchers need to make between sensitivity and speed, enabled by enhancements to our manufacturing and automation processes within our existing high-throughput environment.”
Emily M. Leproust, CEO and co-founder of Twist Bioscience
“Importantly, as MRD providers scale, their supply chains need to keep pace. Our platform is built to support that growth, giving customers confidence to plan beyond today’s testing volumes.”
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Twist panel enables researchers to combine the sensitivity of tumor-informed MRD detection with the speed and simplicity of tumor-naïve MRD detection when developing their tests
Get started
Create a free account to read the full story.